
Sigilon Therapeutics SGTX
Sigilon Therapeutics PEG Ratio | SGTX
Annual PEG Ratio Sigilon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.0744 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0744 | -0.0744 | -0.0744 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ALX Oncology Holdings
ALXO
|
-1.1 | $ 1.11 | -13.62 % | $ 59.6 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-0.293 | $ 21.39 | 0.52 % | $ 6.7 B | ||
|
Phathom Pharmaceuticals
PHAT
|
1.06 K | $ 5.45 | 2.16 % | $ 397 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
1.34 | $ 3.8 | 2.15 % | $ 728 M | ||
|
Agenus
AGEN
|
0.4 | $ 7.02 | -1.82 % | $ 209 M | ||
|
AbCellera Biologics
ABCL
|
0.17 | $ 12.44 | -0.52 % | $ 3.72 B | ||
|
Artelo Biosciences
ARTL
|
-0.000128 | $ 2.14 | 2.01 % | $ 405 K | ||
|
Immatics N.V.
IMTX
|
2.14 K | $ 6.42 | -0.23 % | $ 785 M | ||
|
Aptevo Therapeutics
APVO
|
-0.000004 | $ 1.08 | -4.42 % | $ 341 K | ||
|
Aligos Therapeutics
ALGS
|
-0.0104 | $ 2.59 | -34.43 % | $ 25.6 M | ||
|
Aclaris Therapeutics
ACRS
|
2.62 | $ 4.13 | -2.5 % | $ 506 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
2.84 | $ 29.38 | -2.91 % | $ 4.46 B | ||
|
Cellectar Biosciences
CLRB
|
-0.00121 | $ 1.24 | -3.15 % | $ 3.23 M | ||
|
Larimar Therapeutics
LRMR
|
0.477 | $ 2.68 | 5.93 % | $ 223 M | ||
|
Biofrontera AG
BFRA
|
0.312 | - | -8.24 % | $ 105 M | ||
|
Pliant Therapeutics
PLRX
|
0.0197 | $ 0.78 | -2.19 % | $ 47.9 M | ||
|
Pharming Group N.V.
PHAR
|
-1.94 | $ 13.02 | -1.06 % | $ 8.97 B | ||
|
Catabasis Pharmaceuticals, Inc.
CATB
|
0.0518 | - | -6.97 % | $ 657 M | ||
|
Capricor Therapeutics
CAPR
|
-0.494 | $ 8.91 | -9.54 % | $ 414 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 29.06 | -1.09 % | $ 1.36 B | ||
|
China Biologic Products Holdings, Inc.
CBPO
|
2.73 | - | 1.68 % | $ 4.65 B | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 3.52 | -0.56 % | $ 376 M | ||
|
Jaguar Health
JAGX
|
-0.00477 | $ 0.44 | -0.21 % | $ 1.03 M | ||
|
Arvinas
ARVN
|
31.3 | $ 6.9 | 2.07 % | $ 489 M | ||
|
Cerus Corporation
CERS
|
0.951 | $ 1.95 | -6.04 % | $ 372 M | ||
|
Beam Therapeutics
BEAM
|
-1.32 | $ 25.16 | -6.88 % | $ 2.49 B | ||
|
Pulmatrix
PULM
|
-0.547 | $ 1.39 | 2.58 % | $ 5.08 B | ||
|
Fortress Biotech
FBIO
|
0.00811 | $ 1.9 | -4.52 % | $ 53 M | ||
|
Inhibrx
INBX
|
-0.158 | $ 90.63 | -1.21 % | $ 4.27 B | ||
|
Entera Bio Ltd.
ENTX
|
0.516 | $ 3.24 | -0.31 % | $ 150 M | ||
|
Flexion Therapeutics, Inc.
FLXN
|
0.129 | - | - | $ 459 M | ||
|
Legend Biotech Corporation
LEGN
|
-0.066 | $ 20.25 | -16.63 % | $ 7.46 B | ||
|
CytomX Therapeutics
CTMX
|
0.447 | $ 2.0 | 0.76 % | $ 276 M | ||
|
Krystal Biotech
KRYS
|
2.07 | $ 306.47 | 1.13 % | $ 8.87 B | ||
|
Kura Oncology
KURA
|
0.456 | $ 7.56 | -0.13 % | $ 663 M | ||
|
Inhibikase Therapeutics
IKT
|
0.455 | $ 1.58 | -6.25 % | $ 155 M | ||
|
Heron Therapeutics
HRTX
|
0.175 | $ 0.38 | 1.38 % | $ 63.3 M | ||
|
Inovio Pharmaceuticals
INO
|
-0.003 | $ 1.47 | -2.98 % | $ 68.9 M | ||
|
Corvus Pharmaceuticals
CRVS
|
1.32 | $ 11.36 | 0.09 % | $ 897 M | ||
|
Aytu BioScience
AYTU
|
-0.00535 | $ 1.83 | 2.23 % | $ 22.5 M | ||
|
Heat Biologics, Inc.
HTBX
|
-0.0413 | - | -5.76 % | $ 99.8 M | ||
|
Innoviva
INVA
|
0.012 | $ 19.08 | 0.39 % | $ 1.29 B | ||
|
BioCardia
BCDA
|
-0.00515 | $ 0.95 | 2.66 % | $ 6.33 M | ||
|
Kindred Biosciences, Inc.
KIN
|
0.138 | - | 0.11 % | $ 419 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 2.3 | -5.35 % | $ 14.7 B | ||
|
Shineco, Inc.
TYHT
|
0.00247 | - | -3.90 % | $ 97.2 M | ||
|
Millendo Therapeutics, Inc.
MLND
|
-0.00169 | - | -5.36 % | $ 20.2 M | ||
|
Certara
CERT
|
-13 | $ 12.21 | -0.08 % | $ 1.96 B | ||
|
Dyadic International
DYAI
|
0.649 | $ 0.39 | 1.16 % | $ 14.1 M | ||
|
Intec Pharma Ltd
NTEC
|
-0.0162 | - | -12.45 % | $ 17.7 M |